Print

Omnicell to Present at Lazard Capital Markets 9th Annual Healthcare Conference  
11/8/2012 1:09:10 PM

MOUNTAIN VIEW, Calif., Nov. 7, 2012 /PRNewswire/ -- Omnicell, Inc. (NASDAQ:OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced they will present at Lazard Capital Markets 9th Annual Healthcare Conference at the Pierre Hotel, New York, NY.

(Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a)

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, executive vice president & CFO

Date:Wednesday, November 14, 2012
Time: 10:30 a.m. ET
Location: The Pierre Hotel, New York, NY
Availability: The audio-webcast of the live presentation may be accessed by visiting:
http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.

MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.

For more information about Omnicell, please visit www.omnicell.com. Visit www.mts-mt.com for more information about MTS.

OMCL-E

SOURCE Omnicell, Inc.


//-->